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Abstract Impairment of cognitive performance during
and after high-altitude climbing has been described in
numerous studies and has mostly been attributed to cere-
bral hypoxia and resulting functional and structural cere-
bral alterations. To investigate the hypothesis that high-
altitude climbing leads to cognitive impairment, we used of
neuropsychological tests and measurements of eye move-
ment (EM) performance during different stimulus condi-
tions. The study was conducted in 32 mountaineers
participating in an expedition to Muztagh Ata (7,546 m).
Neuropsychological tests comprised figural fluency, line
bisection, letter and number cancellation, and a modified
pegboard task. Saccadic performance was evaluated under
three stimulus conditions with varying degrees of cortical
involvement: visually guided pro- and anti-saccades, and
visuo-visual interaction. Typical saccade parameters
(latency, mean sequence, post-saccadic stability, and error
rate) were computed off-line. Measurements were taken at
a baseline level of 440 m and at altitudes of 4,497, 5,533,
6,265, and again at 440 m. All subjects reached 5,533 m,
and 28 reached 6,265 m. The neuropsychological test
results did not reveal any cognitive impairment. Complete
eye movement recordings for all stimulus conditions were
obtained in 24 subjects at baseline and at least two altitudes
and in 10 subjects at baseline and all altitudes. Measure-
ments of saccade performances showed no dependence on
any altitude-related parameter and were well within normal
limits. Our data indicates that acclimatized climbers do not
seem to suffer from significant cognitive deficits during or
after climbs to altitudes above 7,500 m. We demonstrated
that investigation of EMs is feasible during high-altitude
expeditions.
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Introduction
An ever-increasing number of recreational climbers
attempt ascents of summits of extreme altitudes. The
Nepalese Ministry of Tourism and Civil Aviation and the
Nepal Mountaineering Association reported having issued
permits to 6,032 climbers for peaks higher than 6,000 m in
the year 2010 alone. Summits of very high altitude exist
and are also often climbed in other parts of the Himalayas
and in South America and Alaska.
Alterations in cognitive performance during and after
high-altitude climbing have been described in numerous
reports (Lieberman et al. 1995; Abraini et al. 1998) and have
mostly been attributed to cerebral hypoxia caused by low
atmospheric oxygen partial pressure and to functional cere-
bral impairment due to acute mountain sickness (AMS) or
high-altitude cerebral edema (HACE) (Virues-Ortega et al.
2004). The possibility of long-term cerebral damage and
impairment from exposure to extreme hypoxia and the
resulting hypoxemia has been a topic of controversy for
decades (West 1986). Several investigators have found per-
sistent neuropsychological deficits in high-altitude climbers
(Hornbein et al. 1989; Regard et al. 1989). Other authors have
documented persisting structural cerebral changes with
magnetic resonance imaging (MRI) (Fayed et al. 2006;
Garrido et al. 1993) after high-altitude climbs. Fayed et al.
(2006) reported brain lesions in mountain climbers detected
by means of conventional MRI and magnetic resonance
spectroscopy (MRS) after an ascent to relatively moderate
altitudes of 4,800 m in the French Alps (Fayed et al. 2006). In
contrast to these studies, other investigators did not observe
any significant changes either in brain imaging results
(Anooshiravani et al. 1999) or in neuropsychological testing
(Jason et al. 1989) after expeditions to heights between
5,334 m (high altitude) and 7,500 m (extreme altitude).
A possible explanation for these ambiguous findings is
that most neuropsychological tests do not discriminate
between cognitive impairment due to neuronal dysfunction
and behavioral changes caused by other factors such as
fatigue, mood fluctuations and lack of motivation (Nicolas
et al. 2000). The overall reliability of many experimental
results may have been affected by the small number of
subjects included in most previous studies, the inter-subject
variability inherent to standard neuropsychological testing
and the difficulty of carrying out more complex neuro-
logical examinations at high altitudes.
The aim of the prospective cohort study at hand was
to evaluate cognitive functions in a large group of
climbers before, during, and after an expedition to high
altitudes, independent of the above-mentioned con-
founding factors. Prerequisite for the applied method was
a high sensitivity for detection of deterioration of cere-
bral function, a high inter-rater and test–retest reliability,
and a low intra-individual variation of baseline mea-
surements in normoxic conditions. For this purpose, we
recorded visually elicited saccades in mountain climbers
and compared their results with those obtained from an
array of traditional neuropsychological tests. Saccadic
eye movements, which very quickly and accurately
change the eye’s position, have been studied for decades
in both humans and animals. The various networks
involved in their control have been localized and char-
acterized by numerous experiments in animals using
single cell recordings, as well as by behavioral investi-
gations in animals, normal subjects, and patients using
eye movement recordings, or functional studies using
magnetic resonance imaging (fMRI) or transcranial
magnetic stimulation (TMS) (Leigh and Kennard 2004).
The fact that eye movements can be recorded at a very
high temporal and spatial resolution (Collewijn et al.
1975) has been of particular benefit for investigators
since reliable parameters of brain function can be
deduced from such eye position tracks. Depending on the
stimulus condition, these parameters may help to distin-
guish pathological conditions such as muscular/neuro-
muscular fatigue (Barton et al. 1995) from various
cortical and/or subcortical dysfunctions, including lack of
attention (Gaymard et al. 1998; Pierrot-Deseilligny et al.
1991) as well as motivation.
The decline in saccadic eye movement performance is
a sensitive marker even for minor impairment of cerebral
function in various physiological and pathological con-
ditions. Sleep deprivation for 24 h has been reported to
impair peak velocity of saccades and to lead to deficits
of accuracy and latency (Fransson et al. 2008). As
compared to placebo, low-dose lorazepam (1–2 mg)
significantly increases saccade latency and decreases
peak velocity (Masson et al. 2000). Similar effects can
be seen after consumption of moderate amounts of eth-
anol (Vorstius et al. 2008). In addition, specific and
marked impairment of saccadic eye movements have
been reported in early Alzheimer’s (Yang et al. 2012),
mild frontotemporal dementia (Boxer et al. 2006), and in
post concussion syndrome (Heitger et al. 2008). To our
knowledge, this is the first report on saccadic eye
movements in the context of prolonged hypobaric
hypoxia.
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Methods
Objectives
To evaluate cognitive functions in a large group of
climbers before, during, and after exposure to hypobaric
hypoxia in the context of an expedition to extreme
altitudes.
Participants
Thirty-two experienced non-professional mountaineers (7
females, 25 males) with a mean age of 43 years (range
25–62 years) participated in The Swiss High-Altitude
Research Expedition Muztagh Ata carried out on Mount
Muztagh Ata (7,546 m) in western China. All subjects
were lowland residents residing below 1,400 m. Exclusion
criteria were cardiac and/or respiratory diseases, regular
medication, previous history of high-altitude pulmonary
edema after a rapid ascent (\3 nights) at altitudes below
3,500 m, and previous history of severe AMS or high-
altitude cerebral edema after rapid ascent to altitudes below
3,500 m.
Altitude measurements
The subjects were randomly assigned to two groups
ascending at slightly different rates. Each group consisted
of 16 mountaineers, who were to climb from 3,750 m (day
1 of expedition) to the base camp (BC = 4,497 m), camp 1
(C1 = 5,533 m), camp 2 (C2 = 6,265 m), camp 3
(C3 = 6,865 m) and to the summit (7,546 m). Daily
assessment of symptoms and signs of AMS and high-alti-
tude pulmonary edema (HAPE) was performed. AMS was
determined by means of the Lake Louise AMS protocol
and the cerebral score on the environmental symptoms
questionnaire (AMS-C score) (Sampson et al. 1983). The
Lake Louise Protocol includes a self-reported question-
naire in combination with a clinical assessment. The
questionnaire involves individual subject ratings of head-
ache, gastrointestinal symptoms, fatigue, dizziness, and
difficulty in sleeping [individual scores from 0 (absence of
symptoms) through 3 (severe symptoms); overall subject
score 0 (no signs of AMS) through 15 (maximum)]. For the
clinical assessment, subjects were examined for changes in
mental status, ataxia, and peripheral edema. Changes in
mental status and ataxia (heel-to-toe walking test) were
rated from 0 (no signs) to 4 (coma) points, while peripheral
edema was rated as 0 points (no edema), one point
(peripheral edema present in one location) or two points
(peripheral edema present in more than one location). The
Lake Louise AMS score (LLS) was calculated by adding
the scores of all eight items: a score C5 defined the
presence of AMS. To obtain the AMS-C score, the subject
was asked eleven questions about the following symptoms:
light-headedness, headache, dizziness, dim vision, diffi-
culties with coordination, gastrointestinal upset, hangover
sensation and loss of appetite, and weakness; points were
assigned from 0 (no symptoms at all) to 5 (extreme
symptoms). The average value of the severity of each
symptom in the group was used to calculate the mean score
of cerebral (AMS-C), scores greater than 0.7 defined the
presence of AMS. The individual mean arterial oxygen
saturation (SaO2) and the LLS and AMS-C scores for each
subject and every altitude (BC, C1, C2, C3) were calcu-
lated and used for further analysis. Heart rate and arterial
SaO2 were measured by finger pulse oximetry (Onyx 9500
SportStat, Nonin Medical Inc., Plymouth MN, USA). This
pulse oximeter has a three-color pulse-quality indicator and
guarantees an accuracy of ±2 % within the range of
70–100 % SaO2. The climbers warmed their hands prior to
each measurement to ensure good reading quality. Each
expedition member kept a diary on his location in the
morning and the evening, the maximally reached height
during the day, physical activity level, and potential drug
intake. Intake of medication other than NSAIDS was
allowed only upon recommendation by the expedition
physician. Altitude measurements for eye movement
recordings and neuropsychological testing were performed
at BC, C1, and C2. Measurements were performed on the
day following the first night after reaching a new altitude.
No physical activity was allowed during the test days.
Measurements were performed at the same time of the day
for each subject in dedicated high-altitude study sites.
These consisted of large tents that allowed for comfortable
testing conditions and provided sufficient protection from
wind and UV-radiation. Temperatures inside the research
tents ranged from 10 to 25 C. Unlimited amounts of food
and fluids were provided by the expedition’s auxiliary staff.
Coffee but no other stimulant was provided during morning
hours, alcohol was not available throughout the expedition.
Measurement of saccadic eye movement
Eye movement recordings were performed prior to the
expedition, in Zu¨rich (ZH1, 440 m), and at BC, C1, and
C2; all tests were repeated in Zu¨rich (ZH2) 3 months after
the expedition. Subjects were familiarized with the eye
movement tasks during one session at the time of ZH1.
Subjects were seated comfortably at a table with a soft
chin-rest. The right eye position was precisely measured
using a novel, video-based infrared (IR) eye tracker
(OCULOMETRICS, Zurich, Switzerland) with a sampling
rate of 500 Hz and a spatial resolution of 0.1, which is
comparable to the traditional magnetic search coil tech-
nique (Collewijn et al. 1975). If eye movement traces were
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contaminated by blinks, this was detected by the video-
based eye tracker software and the traces were excluded
from all further analyses. After each recording session, eye
movement traces were evaluated by tracking both the pupil
and the limbus. Tracking was performed by first deter-
mining the center of the pupil using a modified circular
Hough transformer, and, by detecting the left and right
pupil edge as well as the left and right border of the iris
using an adaptive edge detection algorithm (Schmitt et al.
2007). Finally, raw IR signals were stored for off-line
analysis. Stimuli were presented on an 18-inch LCD
monitor (Belinea 101920, 1,280 9 1,024 pixels,
376 9 301 mm, 60 Hz), which was positioned 490 mm
from the right, center-aligned eye (visual area subtending
±37 horizontally and ±31 vertically). In addition, a piece
of black cardboard with only a small slit was positioned
close to the subject’s face to prevent inadvertent influences
from the visual surroundings. Each trial started with a
period of fixation (500 ms) on a small center target
(0.8 9 0.8). After successful fixation, the center target
disappeared and a new stimulus was presented for 800 ms.
Subsequently, the trial ended with a dark screen of 200 ms
duration. For each of the three visual paradigms, 126 trials
were recorded in a block during a brief session of *3 min.
Because of the time needed to compute and store the raw
tracking data, a complete test run lasted *30 min. Three
different paradigms were used in the same sequence during
each session at each altitude (Fig. 1):
1. Visually guided pro-saccades (PRO) were used to
assess the state of simple, reflexive eye movements.
The target was presented on a black background at 5,
10, 15, and 20 eccentricity rightwards and leftwards
with the same randomized sequence for all sessions
and subjects.
2. Visually guided, voluntary anti-saccades (ANTI) were
used to assess the ability of frontal neural networks,
including their inter-hemispheric connections, to sup-
press reflexive saccades (top-down task) (Munoz and
Everling 2004). Targets were presented as in the pro-
saccade task, but the subject was required to gaze at a
virtual target in the horizontal mirror position.
3. The visuo-visual interaction paradigm (VVI) was used
to evaluate the performance of extrastriate parietal
brain areas during complex visual stimulation includ-
ing optic flow patterns (Ilg et al. 2006; Schwarz et al.
2010). Targets were presented in the same eccentric-
ities as in the pro-saccade task but on a background
consisting of 300 randomly distributed line elements
(0.2 9 0.8), which was moved downwards for
200 ms at a speed of 11/s at the onset of the trial
(i.e., motion began when the target was presented in a
new location).
Neuropsychological testing
Neuropsychological testing was performed prior to the
expedition in Zu¨rich (ZH1, 440 m) and, subsequently, at
BC, C1, and C2; all tests were repeated in Zu¨rich 3 months
after the expedition. Subjects were familiarized with the
applied neuropsychological tests by performing a trial run
for each test at the time of ZH1. An array of four neuro-
psychological tests was used to evaluate cognitive
functions:
1. The line bisection test (LB) (Schenkenberg et al. 1980)
involves neural circuits of the prefrontal cortex, the
parietal lobes, and several visual processing areas
bilaterally, as well as the cerebellar vermis (Fischer
2001). It consists of 12 black horizontal lines of
100–200 mm length on a sheet of white A4 paper.
Each subject had to mark the center of every line using
his or her dominant hand. The deviation of the
attempted bisection from the true center of each line
was calculated as the percentage of the deviation from
Fig. 1 The three visual paradigms used in this study (see text for
explanations). Visually guided pro-saccades (top panel), visually
guided, voluntary anti-saccades (middle panel), visuo-visual interac-
tion (bottom panel). Arrow direction of required eye movement
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the mark to the midpoint (Braun and Kirk 1999). An
overall mean PD of B5 % was considered normal.
PDscore ¼ 100% D midpoint ½mm
length of line ½mm
2. The 2/7 cancellation test was used to assess verbal
fluency, a measure for bilateral and left frontal brain
regions. The subject was given a sheet of paper with a
series of lines consisting of either letters or numbers in
which the target numbers 2 and 7 were embedded
(Ruff et al. 1992). In the numeric condition, the
numbers 2 and 7 were randomly interspersed with
other numbers (2/7 numbers). In the letter condition,
distracters were letters of the alphabet (2/7 letters). The
test required the subject to cross out the specific targets
(always the numbers 2 and 7) as quickly as possible.
Outcome measures were the time span to complete the
task and the number of errors (missed target digits or
crossed out distracters). Five different versions of the
2/7 test were available and applied in a pre-
randomized order to avoid a learning effect.
3. An applied modified version of the Ruff figural fluency
test (RFFT) was used to evaluate non-verbal fluency,
which predominantly employs functions of the right
frontal lobe (Ruff et al. 1994). Subjects had to generate
different unique designs using straight lines to connect
five dots embedded in a square. The five-dot stimuli
were presented in 35 contiguous templates, which were
arranged in a five-square-by-seven-square grid. Eval-
uated parameters were the time to complete the task,
the number of design repetitions, and the number of
incomplete designs after expiration of the time limit of
3 min.
4. A modified Pegboard test, the Chess test (CT), was
used to globally assess visuo-motor skills. Subjects had
to select chess figures from a covered box and
correctly position them on a small chessboard
(150 9 150 mm). For each session, one of four
possible pre-randomized positions of the chessboard
(rotation of 0–270 in steps of 90) was used. Outcome
measures were time to complete the task and number
of misplaced chess figures.
Data analysis for measurement of saccadic eye
movement
All data processing was performed off-line using a com-
mercial software package (MATLAB 7.6, The MathWorks
Inc., Natick, MA). First, eye position was filtered using an
adaptive smoothing cubic spline. Then, eye velocity was
obtained by a two-point differentiation. Finally, saccades
were detected automatically using combined velocity and
acceleration criteria (Schwarz and Miles 1991). For each
paradigm and eccentricity (with rightward and leftward
saccades combined), the latency (time between target
movement and saccade onset), post-saccadic accuracy
(difference between target and eye position over an interval
of 50 ms), and the saccade main sequence (Lebedev et al.
1996; Becker 1989), as well as the number of correct trials,
were determined. The saccadic main sequence denotes the
relationship between the peak velocity of the eye move-
ment and the displacement as follows:
Vpeak ¼ V0  1  exp D eye poss
  
V0 the saturation velocity, s amplitude for which peak
velocity reaches 63 % of V0.
Due to missing data, subjects were analyzed in three
subgroups (S1 to S3) (Table 2). S1 comprises all subjects
participating in the study. S2 includes subjects who were
evaluated in ZH1 and ZH2 and on at least two altitudes. A
one-way analysis of variance (ANOVA) followed by a post
hoc test (Scheffe´) was applied to their data. Finally, S3
includes only subjects for whom all 15 recordings were
available, and for whom a repeated measures ANOVA was
therefore applicable (StatView 5.0.1, SAS Institute Inc.,
Cary, NC). The use of significance level of p \ 0.01 is a
standard in the field of visuo-motor research, thus a p value of
\0.01 was considered significant for all eye movement
statistics.
Data analysis for neuropsychological testing
A mixed design analysis of variance which accounts for
missing values, was applied to the results of the neuro-
psychological tests (mean ± SD) at different altitudes,
followed by a multiple comparison test (Scheffe´ test).
Within-subject factors were SO2, LLs, and AMS-c,
respectively. A p value of \0.05 was considered statisti-
cally significant.
Ethics approval
The study was approved by the Ethics Committee of the
University Hospital of Zu¨rich and adhered to the tenets of
the Declaration of Helsinki. Informed, written consent was
obtained from all participants.
Results
All of the 32 subjects in the present study reached C1, and
28 reached C2. C3 was reached by 24 climbers and the
summit by 17. Two participants were not allowed to climb
Eur J Appl Physiol (2013) 113:2025–2037 2029
123
beyond 5,400 m, one due to severe mountain sickness and
lack of physical fitness, and the other due to insufficient
skiing skills. Two subjects chose to abort the climb
between C1 and C2, and four subjects between C2 and C3
because of exhaustion and lack of motivation. The two
groups reached the summit at 7,546 m within 20–21 days.
From the start of the climb at 3,750 m, the mean ascent rate
was 191–201 m/d. Table 1 shows individual mean SaO2
for each altitude at which data were obtained. SaO2 sig-
nificantly decreased at higher altitudes, whereas the indi-
vidual mean LLS and mean AMS-C scores of the
expedition members showed a trend toward decrease, but
no significant differences. Depending on the scoring sys-
tem applied, 29 of 32 subjects (90.6 %) (LLS[5) or 22 of
32 subjects (68.7 %) (AMS-C [0.7) experienced at least
one episode of AMS during the course of the expedition.
LLS and AMS-C scores correlated significantly (Spearman
correlation coefficient = 0.6226, p \ 0.001).
Eye movement experiments
Figure 2 is a representative sample showing the main
sequence and the latency distribution of horizontal eye
positions sampled during the VVI paradigm of a study
subject at C1. The corresponding computation of the typ-
ical saccade parameters from the eye movement traces is
shown in Fig. 3. No difference in either saccade latency or
main sequence at different altitudes was found in our
subjects. Figure 4 is an example of latency results from the
one-way ANOVA with post hoc test (multiple compari-
sons) for the same subject. The data clearly show the tight
clustering around typical means (PRO 171 ± 9 ms, ANTI
263 ± 15 ms, VVI 250 ± 10 ms) at all altitudes. Only the
ANTI latencies at BC were statistically different when
compared to the ZH2 results (p \ 0.01). Table 2 lists for
all recordings the percentage of such significant differences
observed in a particular session, which was very small for
all subgroups.
In the group S1 comprising of all subjects participating
in the study no distinct differences in the main parameters
compared to S2 and S3 were found. The subject subgroup
S2 comprised of twenty-four (4 females, 20 males)
climbers who were evaluated in ZH1 and ZH2 and on at
least two altitudes. This group was used to examine pos-
sible dependencies of the eye movements on altitude. In
order to look for inter-individual trends, all data were
normalized with respect to the mean of the ZH2 results.
Although there were apparent weak trends in both, latency
(slightly shorter at higher altitudes, Fig. 5) and the main
sequence (slightly faster at higher altitudes, Fig. 6), the
results were statistically not significant (note the narrow
window of only ±0.2, which was necessary to illustrate
these trends). Figure 7 shows the percentage of correct
trials for the different paradigms at different altitudes. All
differences were consistent and similar for all altitudes. A
one-way ANOVA with post hoc test was applied for
latencies and main sequences for all three paradigms. All
grand mean values were within normal ranges of the
respective task (latency: PRO 179 ms, ANTI 264 ms, and
VVI 270 ms; main sequence: PRO 548/s, ANTI 466/s,
VVI 552/s). Again, there were no significant parameter
differences with respect to altitude.
The subgroup S3 comprised of ten subjects (2 females, 8
males) with complete data sets for every paradigm at every
altitude, and was used to confirm the above results using a
traditional repeated measures ANOVA. As expected, the
procedure revealed a significant effect of the factor para-
digm (latency: p \ 0.0001, main sequence: p \ 0.0013)
but not of the factor altitude (latency: p = 0.0449, main
sequence: p = 0.0230). Similar to saccadic latency and the
main sequence, post-saccadic accuracy was independent of
the altitude and entirely within the normal range. Further-
more, a thorough visual inspection of all saccades did not
reveal any potential pathology, such as catch-up saccades,
post-saccadic glissades, and/or post-saccadic drifts.
Neuropsychological experiments
Data was recorded for 32 subjects on all altitudes from
ZH1 to C1, and in 24 subjects on all altitudes from ZH1 to
C2. Data in ZH2 was again recorded in all 32 subjects.
Table 3 shows the results of the different neuropsy-
chological tests with respect to altitude, SaO2, and degree
of AMS expressed by LLS and AMS-c. In the LB test the
subjects showed a mean PD of 2.5 ± 0.7 % in ZH1, and
the altitude measurements at BC, C1, and C2 yielded no
significant changes. After the expedition, PD was
1.9 ± 0.8 %, resulting in a significant overall decrease of
PD (p \ 0.001). None of the subjects showed a PD C5 %
on any measurement. LB results were not correlated with
either SaO2 or AMS scores. The time needed to complete
Table 1 Oxygen saturation and mountain sickness at different
altitudes
BC C1 C2 C3 p
SaO2 (%) 83.5 ± 2.8 77.9 ± 4.5 74.7 ± 5.7 70.0 ± 6.0 \0.0001
LLs
(points)
2.2 ± 1.0 2.9 ± 1.6 3.3 ± 1.7 3.5 ± 2.3 0.015
AMS-c
(points)
0.1 ± 0.1 0.2 ± 0.2 0.3 ± 0.4 1.69 ± 2.09 Ns
LLs acute mountain sickness (AMS) assessed by applying the Lake Louise
AMS protocol; AMS-c AMS assessed by applying the cerebral score of the
environmental symptoms questionnaire; BC base camp (4,497 m); C1 camp 1
(5,533 m); C2, camp 2 (6,265 m); SaO2 arterial oxygen saturation measured by
pulse oximetry; ns not significant
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the 2/7 numbers and the amount of errors showed no cor-
relation with altitude, SaO2 or AMS scores. The amount of
time required to complete the 2/7 letters decreased signif-
icantly, from 66.1 ± 16.9 s (ZH1) to 52.7 ± 22.1 s (C2),
and displayed a non-significant increase to 55.2 ± 16.6 s
in ZH2; accordingly, we found a significant negative cor-
relation with AMS-c but not with LLS or SaO2. No cor-
relation existed between error amount and altitude, SaO2 or
AMS scores. The time required to complete the RFFT
significantly decreased from 132.1 ± 32.8 s in ZH1 to
96.9 ± 40.2 s at C2, and increased to 106.2 ± 42.1 s in
ZH2. There was a negative correlation with AMS-C,
whereas the amount of repetitions was not correlated with
altitude, SaO2 or AMS scores. The time to complete the CT
revealed no significant correlations as well.
Discussion
The findings of our study can be summarized as follows:
the well-acclimatized climbers generally did not suffer
from significant effects of hypoxia on their cognitive per-
formance during and after a prolonged stay at very high
altitudes. The behavior of eye movements was in close
agreement with the results of traditional neuropsychologi-
cal tests. It was possible to reliably record eye movements
during a high-altitude expedition for the first time.
Saccadic performance has been reported to be a sensi-
tive marker even for minor impairment of cerebral per-
formance in various physiological and pathological
conditions (Green and King 1998; Heitger et al. 2008;
Yang et al. 2012). Saccadic eye movement studies offer a
Fig. 2 Main sequence and latency distribution of horizontal eye positions sampled during the VVI paradigm of one subject at C1. Note post-
saccadic accuracy and stability for all eccentricities
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number of advantages in the evaluation of cerebral per-
formance and possible impairment in the context to pro-
longed exposure to hypoxic conditions at high altitudes.
The experiments measure physiological data without
human interaction during the recording period and thus
exclude observer-related bias. In addition, the stimulus
paradigms and recording times can easily be adjusted to the
goal of the study. The different yet consistent patterns that
were obtained from the saccadic parameters in our subjects
reveal that the responses to the three visual paradigms were
mediated by different cortical networks—including all
known cortical/subcortical and infratentorial optomotor
areas—and would have allowed easy detection of perfor-
mance impairment. There were a small number of statis-
tically significant differences in the results. However, the
aberrations were too small and random to indicate a true
and systematic optomotor deficit, since such failures would
produce a more dramatic, persistent, and well-known
pathological pattern in the eye movement parameters.
Muscular and/or neuromuscular fatigue would result in a
pattern consisting of more and more catch-up saccades and
glissades (Bahill and Stark 1975), and/or the saturation
velocity would significantly decrease during the strenuous
9 min of forced eye movements, as is observed in ocular
myasthenia (Barton et al. 1995; Spooner and Baloh 1979).
Cortical deficits exhibit typical patterns depending on the
lesion site. Even a partial breakdown of a neural network
results in either missing a chain of neurons with well-
known transmission times (e.g., appearance of express
Fig. 3 Computation of typical saccade parameters from the eye
movement traces shown in Fig. 2. Main sequence (top panel) with
saturation velocity (V0) and velocity at 63 % (s) shown as white
circles, CI confidence intervals; latency distribution (bottom panel)
with mean ± SD shown as white circle and bold lines. Note
cumulative frequency was divided by 10 to fit it into the axes
Fig. 4 One-way ANOVA with post hoc test (Scheffe´) for all
latencies of subject 12. The number of trials for each condition is
shown at the bottom of each axis
2032 Eur J Appl Physiol (2013) 113:2025–2037
123
Table 2 Statistical results for three subgroups of subjects
Subjects Sessions APH Trials Stimulus condition
PRO ANTI VVI
V0 (/s) Latency (ms) V0 (/s) Latency (ms) V0 (/s) Latency (ms)
Subgroup 1 (n = 32) 396 6.6 31,061 539 ± 72 184 ± 18 453 ± 75 271 ± 31 550 ± 76 271 ± 25
Subgroup 2 (n = 24) 315 5.7 25,308 548 ± 71 180 ± 18 469 ± 80 266 ± 32 559 ± 75 271 ± 27
Subgroup 3 (n = 10) 150 4.0 12,052 536 ± 60 179 ± 21 453 ± 81 270 ± 28 544 ± 54 268 ± 21
Note the similarity for all data across the three subgroups and the small percentage of significantly different results
Subjects number of subjects in each subgroup. 1 all subjects; 2 subjects with at least two recording sessions in BC, C1, or C2, and at least one
session in ZH1 or ZH2 for each stimulus condition; 3 subjects with a full set of 15 recording sessions, which were used for the repeated measures
ANOVA. APH percentage of sessions with results which were significantly different (p [ 0.01) in the ANOVA post hoc test. Trials number of
valid saccades. Values are grand mean ± SD for the mean data of each subject’s recording session. V0 asymptotic limit for the maximum speed
of the main sequence (see text). Stimulus conditions: PRO visually guided pro-saccades; ANTI anti-saccades; VVI visuo-visual interaction
Fig. 5 Mean ± SD of normalized latencies for each paradigm at
each altitude of subgroup 2
Fig. 6 Mean ± SD of normalized saturation velocities for each
paradigm at each altitude of subgroup 2
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saccades with latencies of less than 100 ms), or activation
of an auxiliary or corollary network, which would not
perform as precisely and thus lead to post-saccadic errors
(Leigh and Zee 1999; Gaymard et al. 1998; Pierrot-Des-
eilligny et al. 2004). In addition, attention deficits (partic-
ularly due to parietal and/or frontal lobe deficits) would
manifest themselves in the same way, as the attention
system shares a multitude of cortical networks with the
optomotor system (Nobre et al. 2000; Corbetta et al. 1998).
Changes in the extrapyramidal system, which is also very
vulnerable to hypoxic trauma, would produce frequent
saccadic intrusions due to lack of control of the superior
colliculus, which governs various saccade generators in the
brainstem (Weber et al. 2000). Cerebellar and/or cerebello-
pontine lesions would quickly produce noticeable problems
with the post-saccadic stability, e.g., gaze-evoked nystag-
mus. While the analysis of eye movements will easily be
able to detect deficits due to global hypoxia, single lesions
caused by other events, such as a small focal ischemia, may
not always produce typical eye movement patterns or
typical neuropsychological findings.
The assessment of the climbers using conventional
neuropsychological test did not reveal any significant cor-
relation of changes of cognitive function to the severity of
hypoxia measured by pulse-oximetric SaO2. We did find a
negative correlation with AMS-c scores (but not LLS
scores) for the 2/7 letters and the RFFT time to completion,
thus the performance improved significantly in those
climbers with more AMS symptoms. Similarly, the bisec-
tion precision was significantly better in the last test of the
series and there was a significant decrease in time to
complete 2/7 letters at higher altitudes. Nevertheless, none
of the neuropsychological test results revealed any evi-
dence for impairment of cognitive function in hypoxic
conditions. We assume that the significant increases in
performance seen in the altitude measurements of some of
the test are attributable to retest bias. In the context of
standard neuropsychological assessments, test–retest reli-
ability can be influenced due to practice effects related to
both declarative (e.g., remembering the actual items on the
tests) and procedural (e.g., remembering how to do the test)
memory. Novelty effects (during the initial evaluation a
test is novel to the subject, on repeat testing, the test
becomes familiar) can increase or decrease performance
(Suchy et al. 2010). Test–retest reliability can also be
influenced by the retest interval (Heilbronner et al. 2010)
and by floor and ceiling effects (Duff 2012). The applied
neuropsychological tests are reported to have a compara-
tively high test–retest reliability (Basso et al. 1999) and our
subjects were familiarized with the test procedures to
reduce test–retest bias. Nevertheless, longitudinal within-
subject reliability is considerably higher in eye movement
Fig. 7 Mean ± SD percentage of correct trials for each paradigm at
each altitude of subgroup 2
Table 3 Statistical results of neuropsychological tests
Test Parameter Corr. to altitude Corr. to SaO2 Corr. to LLs Corr. to AMS-c
LB PD Ratio p \ 0.001* Ns Ns Ns
2/7 numbers Time Ns Ns Ns Ns
Errors Ns Ns Ns Ns
2/7 letters Time p \ 0.001* Ns Ns p = 0.04
Errors Ns Ns Ns Ns
RFFT Time Ns Ns Ns p = 0.01
Repetitions Ns Ns Ns Ns
CT Time Ns Ns Ns Ns
Summary result of the neuropsychological tests performed in ZH1, BC, C1, C2, and ZH2
SaO2 arterial oxygen saturation; LLs acute mountain sickness (AMS) assessed by applying the Lake Louise AMS protocol; AMS-c AMS assessed
by applying the cerebral score of the environmental symptoms questionnaire; LB PD mean deviation of the attempted bisection from the true
centre of each line in percentage of the line length in line bisection test; 2/7 numbers 2 and 7 cancellation test applying numbers as distracters; 2/7
letters 2 and 7 cancellation test applying letters as distracters; RFFT Ruff figural fluency test; CT chess test
* Significant decrease in time needed to perform the test at different altitudes
 Significant negative correlation to AMS-c score
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assessments (Wilson et al. 1993). This underlines our
hypothesis, that standard neuropsychological testing might
not be the optimal method to repeatedly assess cognitive
function in the context of a high-altitude expedition—as
outlined in the introduction.
Our study has a number of strengths and weaknesses.
Despite substantial technical and logistical difficulties we
were able to conduct a prospective investigation of cog-
nitive performance in a large group of climbers during and
after exposure to extreme altitudes. The high altitude of the
camps and the summit did lead to very significant hypoxia
and to a substantial number of participants suffering from
altitude-related illnesses. As reported elsewhere, the inci-
dence of suspected, clinically not apparent brain edema
was high in the examined subjects (Bosch et al. 2008).
Thus, the fact that we did not find any impairment of
cognitive performance in our subjects cannot be attributed
to insufficiently severe hypoxic conditions. The examined
group consisted of amateur and not elite climbers of all age
groups—in essence representing the growing population of
recreational high-altitude sojourners.
The main study limitations were caused by the logistical
restrictions of the research facilities at high altitudes. Data
recording for the eye movement studies required 30 min
per subject and altitude and was vulnerable to the unreli-
able power supplied by generators. In addition, due to
adverse weather conditions, not all subjects reached the
high-altitude research facilities in time to complete all
planned eye movement recordings. However, we were able
to record the majority of planned studies in each subject.
The data sets before and after the expedition (ZH1 and
ZH2) were complete, which underlines the validity of our
findings excluding long-term cognitive impairment. This is
a very important result as long-term cognitive impairment
would clearly mandate to discourage climbers to attempt
summits of high altitude. In 24 climbers ZH1 and ZH2
measurements of eye movements as well as at least two
altitude measurements were completed. Complete data sets
for all stimulus conditions on all altitudes were obtained
only in the ten subjects in group S3. However, a true and
systematic optomotor deficit would have produced a very
clear, persistent, and well-known pathological pattern in
the eye movement parameters. Such a deficit would have
been detectable even when analyzing eye movement per-
formance in the group S2 with missing values or in a small
group of subjects such as the ten in group S3. Detectable
impairment of cognitive function occurring during the
climb would indicate a markedly increased risk for
climbing-related incidents.
The variable individual reactions to environmental stress
factors such as low ambient temperature, UV radiation,
physical exercise, and mental stress could have influenced
cognitive performance; these factors are difficult to
measure and to correct for. However, we assume that
environmental stress factors would impair rather than
improve cognitive function. It therefore seems unlikely that
a hypoxia-induced reduction in cognitive performance was
masked by the influence of other, non-measured factors.
Due to diligent acclimatization tactics and constant moni-
toring of all subjects and staff exposed to hypoxic condi-
tions, we were able to avoid any occurrence of severe AMS
or clinically apparent HACE. Our findings thus cannot
exclude the possibility of cognitive impairment or long-
term cerebral damage occurring after such an event.
We conclude that severe hypobaric hypoxia is well
tolerated in healthy high-altitude climbers, without any
indication of acute or long-term impairment of cognitive
functions. Furthermore, we demonstrated that the investi-
gation of eye movements is feasible during high-altitude
expeditions and could represent a valuable tool for the
study of human cognitive function under a variety of
environmental conditions.
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